Thursday, August 11, 2011

Novelta exhibits higher acid neutralizing capacity than conventional antacid

According to guideline of USFDA an antacid must have a Acid Neutralizing capacity > 5 mEq (milliequivalent) and an effective antacid must have higher and prolonged acid neutralization capacity. Orion Pharma Ltd. Introduces 1st time in Bangladesh- Novelta, A novel antacid. A comparative study was performed to compare the acid neutralizing capacity of all the available antacids. Among them, Magaldrate and Simethicone combination (Novelta) has the higher acid neutralizing capacity.





A novel antacid to treat Hyperacidity, Heartburn, Gastric & Duodenal Ulcer, Dyspepsia, GERD & Flatulence
Indications Hyperacidity, Gastric & Duodenal ulcer, Gastritis, Heartburn, Dyspepsia, Gastroesophageal reflux. Also indicated for the relief of Flatulence, Abdominal distention and Windy colic.
Dosage and Administration 2-4 teaspoonful (10-20 ml) or1-4 tablets of Novelta chewable tablet, 20 minutes to 1 hour after meals and at bedtime, or as directed by physician.
Available as: Novelta Suspension 100 ml Novelta Suspension 200 ml Novelta Chewable Tablet."


Sunday, July 10, 2011

Top Pharmaceutical Company of Bangladesh: 2011

Tk (Crore) Share Growth %
Rank Total Market 7,186 100.00 24.30
1 SQUARE 1,378 19.18 23.54
2 INCEPTA PHARMA 650 9.05 32.17
3 BEXIMCO 620 8.62 40.33
4 OPSONIN PHARMA 355 4.94 26.09
5 ESKAYEF 348 4.84 24.82
6 RENATA 340 4.73 29.63
7 ACME 319 4.44 17.34
8 A.C.I. 293 4.08 18.81
9 ARISTOPHARMA 286 3.99 21.63
10 DRUG INTERNATIONAL 270 3.75 18.18
11 SANOFI AVENTIS 185 2.57 8.77
12 GLAXOSMITHKLINE 140 1.95 10.84
13 ORION PHARMA LTD. 140 1.94 31.47
14 NOVO NORDISK 128 1.79 27.72
15 HEALTHCARE PHARMA 126 1.75 33.20
16 GENERAL 117 1.63 19.25
17 SANDOZ 109 1.51 12.25
18 POPULAR PHARMA 94 1.31 54.53
19 NOVARTIS 94 1.30 46.01
20 IBN SINA 93 1.29 19.49
21 NUVISTA PHARMA 83 1.16 37.93
22 UNIMED &UNIHEALTH 68 0.94 22.80
23 SUN PHARMA 60 0.84 54.63
24 GLOBE 57 0.80 24.72
25 BIO PHARMA 56 0.78 21.07
26 ROCHE 50 0.70 42.24
27 RADIANT PHARMA 41 0.57 71.73
28 PACIFIC 41 0.57 18.46
29 JAYSON 38 0.52 10.97
30 BEACON PHARMA 37 0.52 18.11
31 SMC 33 0.46 -1.25
32 ORION INFUSION 32 0.45 12.26
33 OPSO SALINE 30 0.42 1.85
34 KEMIKO PHARMA LTD. 29 0.41 4.68
35 NAVANA 29 0.40 -1.94
36 DELTA PHARMA 27 0.38 53.11
37 SERVIER 27 0.37 23.61
38 SOMATEC 23 0.33 4.37
39 RANGS PHARMA 22 0.31 -3.85
40 LIBRA 21 0.30 -4.70
41 ALCO PHARMA 21 0.29 5.44
42 APEX PHARMA 20 0.28 38.84
43 PHARMADESH 19 0.26 80.09
44 SILVA PHARMA 14 0.19 -1.21
45 MEDIMPEX 12 0.17 -50.53
46 EDRUC 11 0.15 -19.17
47 ZISKA 10 0.15 -0.71
48 WHITE HORSE PHARMA 10 0.14 81.65
49 RAK PHARMA LTD. 8 0.12 441.79
50 ASIATIC 8 0.12 65.29
* Others * 162 2.24 0.00


Data Source: Bangladesh Pharmaceutical Index' 1st Q, 2011

Monday, April 25, 2011

Top 20 Pharmaceutical Company of Bangladesh : 2010

Rank

SALE

(Tk Cr.)

Share (%)

Growth (%)

Total Market

6,457.22

24.58

1

SQUARE

1,238.65

19.18

21.28

2

INCEPTA

573.63

8.88

37.79

3

BEXIMCO

528.65

8.19

34.50

4

OPSONIN

316.62

4.90

31.17

5

ESKAYEF

316.49

4.90

29.81

6

RENATA

306.23

4.74

36.98

7

ACME

293.93

4.55

13.64

8

A.C.I

277.16

4.29

21.16

9

ARISTO

260.77

4.04

24.06

10

Drug Int

249.85

3.87

24.48

11

AVENTIS

179.36

2.78

11.58

12

GLAXO

131.61

2.04

7.96

13

ORION LAB.

124.76

1.93

38.69

14

NOVO NORDISK

116.69

1.81

56.39

15

HEALTHCARE

108.30

1.68

30.74

16

GENERAL

105.47

1.63

12.68

17

SANDOZ

90.59

1.40

-3.78

18

IBN SINA

89.60

1.39

30.80

19

POPULAR

72.77

1.13

47.52

20

NOVARTIS

72.60

1.12

22.96


Data Source: Bangladesh Pharmaceutical Index (3Q, 2010)

Why Chewable Antacid is Better in heartburn?

Chewable antacid is more effective in preventing heartburn than swallowing an antacid, because antacids are primarily active in esophageal lumen, rather than neutralization of intragastric contents. When a tablet is swallowed it passes through the stomach too fast to neutralize the acid and when a tablet chewed, the antacid is ready to work as soon as it reaches the stomach.

Sunday, April 24, 2011

Novelta: A Novel Antacid



Brand name : Novelta

Generic name : Magaldrate USP + Simethicone USP

Therapeutic class : Antacid

Dosage form : Chewable Tablet

Strength : (Magaldrate USP 480 mg + Simethicone USP 20 mg)

Pack size : 10x10’s

MRP/Box : Tk. 200 (Tk. 2.00/Tablet)


Indications

Hyperacidity, Gastric & Duodenal ulcer, Gastritis, Heartburn, Dyspepsia, Gastroesophageal reflux. Also indicated for the relief of Flatulence, Abdominal distention and Windy colic.

Mechanism of Action

Magaldrate is a sulfate containing hydroxymagnesium aluminate complex, hydrotalcite like lattice layer structure and a discrete chemical entity rather than a physical mixture of Al (OH)3 & Mg(OH)2. The approximate formula of Magaldrate is Al5Mg10(OH)31(SO4)2.xH2O.

Magaldrate

  • After ingestion of Novelta chewable tablet
  • The hydroxymagnesium is relatively rapidly converted to Magnesium ion
  • The negative charged layer situated between the positive charged layers that soaks up H+ ions
  • Rapid onset of action occurs
  • Aluminate converted to hydrated aluminium hydroxide
  • Reacts more slowly to give a sustained antacid effect
  • Prolonged acid neutralization occurs

    Simethicone

  • Acts in the stomach and intestine

  • Decreases the surface tension of gas bubbles

  • Enabling them to coalesce
  • Gas is freed and eliminated more easily
  • By belching or passing flatus

Dosage and Administration

1-4 tablets of Novelta chewable tablet, 20 minutes to 1 hour after meals and at bedtime, or as directed by physician.

To See Documentary on Novelta Please follow these link: Novelta: A Novel Antacid


Sunday, May 23, 2010

Azithromycin in Acne treatment

Acne is a common inflamatory disorder of the skin. It is a multifactorial disease caused by follicular hyperkeratinization, infection with Propionibacterium acnes, increase sebum production and information.

Dose for Acne: Azithromycin (Azalid) 500 mg tablet, 3 days per week for 8-12 weeks.